← Back to directory

Willem A. Bemelman

Researcher Next ID · RN-033841

Researcher · Biochemistry, Genetics and Molecular Biology

GGD Amsterdam

Amsterdam, Netherlands

Accepting doctoral researchersFunding unknown
Works count
719
Citation count
35,929
H-index
92
i10-index
371

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Colorectal Cancer Surgical Treatments
Inflammatory Bowel Disease
Diverticular Disease and Complications
Anorectal Disease Treatments and Outcomes
Stoma care and complications

Publications

  • The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission

    ˜The œLancet. Gastroenterology & hepatology · 2023 · https://doi.org/10.1016/s2468-1253(23)00003-1

  • STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

    Gastroenterology · 2021 · https://doi.org/10.1053/j.gastro.2020.12.031

  • Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

    ˜The œLancet. Gastroenterology & hepatology · 2020 · https://doi.org/10.1016/s2468-1253(20)30117-5

  • European Society of Coloproctology: guidelines for the management of diverticular disease of the colon

    Colorectal Disease · 2020 · https://doi.org/10.1111/codi.15140

  • Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial

    ˜The œLancet. Gastroenterology & hepatology · 2019 · https://doi.org/10.1016/s2468-1253(19)30239-0

  • Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

    ˜The œLancet. Gastroenterology & hepatology · 2017 · https://doi.org/10.1016/s2468-1253(17)30248-0

  • Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

    The American Journal of Gastroenterology · 2015 · https://doi.org/10.1038/ajg.2015.233

  • A Randomized Trial of Laparoscopic versus Open Surgery for Rectal Cancer

    New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1414882

  • Oncological outcome of malignant colonic obstruction in the Dutch Stent-In 2 trial

    British journal of surgery · 2014 · https://doi.org/10.1002/bjs.9645

  • Oncological outcome of malignant colonic obstruction in the Dutch Stent-In 2 trial

    British journal of surgery · 2014 · https://doi.org/10.1002/bjs.9645

  • A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease

    Gut · 2014 · https://doi.org/10.1136/gutjnl-2013-306709

  • Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial

    The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045(11)70035-3

  • European evidence-based Consensus on the management of ulcerative colitis: Current management

    Journal of Crohn s and Colitis · 2008 · https://doi.org/10.1016/j.crohns.2007.11.002

Current projects

    No projects listed.